Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs iShares TIPS Bond ETF (TIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs iShares TIPS Bond ETF — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while iShares TIPS Bond ETF trades at $105.37 (market cap $14.33B). The key difference: iShares TIPS Bond ETF is far larger — about 14.7× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and iShares TIPS Bond ETF for 64 Days on average.
| MRVI | TIP | |
|---|---|---|
Market Cap | $972.90M | $14.33B |
Volume | 4,325,710 | 1,485,284 |
Sector | Health | Fixed Income |
52-Week High | $9.00 | $112.20 |
52-Week Low | $2.83 | $103.98 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $1.08B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
TIP trades at $104.56 with minimal daily movement (+0.06%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The ETF shows limited price volatility with support at $104 and resistance at $105. Recent institutional activity includes Envestnet Asset Management increasing its stake by 3.5% in the latest quarter.
The ETF faces headwinds from rising Treasury yields and bond market volatility, though its inflation-protected structure provides defensive characteristics. Key risks include continued bond market selloffs and geopolitical tensions affecting oil prices. The upcoming dividend payment of $0.78 scheduled for August 2026 offers income stability amid market uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About iShares TIPS Bond ETF
TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →
